EC Number | Application | Comment | Organism |
---|---|---|---|
6.3.1.20 | synthesis | enzyme-mediated two-step labeling protocol suitable for live-cell labeling using lipoic acid ligase with norbornene substrates and subsequent inverse-electron demand Diels-Alder reaction | Escherichia coli |
EC Number | Cloned (Comment) | Organism |
---|---|---|
6.3.1.20 | recombinant expression of wild-type enzyme and enzyme mutant LplAW37V | Escherichia coli |
EC Number | Protein Variants | Comment | Organism |
---|---|---|---|
6.3.1.20 | additional information | establishment of an enzyme-mediated two-step labeling protocol suitable for live-cell labeling: construction of a fusion protein LAP-eDHFR-His6, in which eDHFR bears an N-terminal LAP extension and a C-terminal His-tag for purification. In the first step, substrate 6-[[(1S,2R,4S)-bicyclo[2.2.1]hept-5-ene-2-carbonyl]amino]hexanoic acid is coupled to purified recombinant LAP-eDHFR. After removal of excess norbornene substrate with centrifugal filter devices, the modified protein is successfully labeled with tetrazine-fluorescein | Escherichia coli |
6.3.1.20 | W37V | LplAW37V-mediated surface labeling of HEK293T cells with 6-[[(1S,2R,4S)-bicyclo[2.2.1]hept-5-ene-2-carbonyl]amino]hexanoic acid and tetrazine-TAMRA, overview. Necessity of a particular chain length to fit the dimensions of the active site of LplAW37V | Escherichia coli |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
6.3.1.20 | Mg2+ | required | Escherichia coli |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
6.3.1.20 | ATP + (R)-lipoate + a [lipoyl-carrier protein]-L-lysine | Escherichia coli | - |
a [lipoyl-carrier protein]-N6-(lipoyl)lysine + AMP + diphosphate | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
6.3.1.20 | Escherichia coli | - |
- |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
6.3.1.20 | ATP + (R)-lipoate + a [lipoyl-carrier protein]-L-lysine | - |
Escherichia coli | a [lipoyl-carrier protein]-N6-(lipoyl)lysine + AMP + diphosphate | - |
? | |
6.3.1.20 | ATP + 5-[[(1R,2R,4R)-bicyclo[2.2.1]hept-5-ene-2-carbonyl]amino]pentanoic acid + a [lipoyl-carrier protein]-L-lysine | - |
Escherichia coli | ? | - |
? | |
6.3.1.20 | ATP + 5-[[(1R,2S,4R)-bicyclo[2.2.1]hept-5-ene-2-carbonyl]amino]pentanoic acid + a [lipoyl-carrier protein]-L-lysine | - |
Escherichia coli | ? | - |
? | |
6.3.1.20 | ATP + 6-([[(1R,4R)-bicyclo[2.2.1]hept-5-en-2-yl]methyl]amino)hexanoic acid + a [lipoyl-carrier protein]-L-lysine | - |
Escherichia coli | ? | - |
? | |
6.3.1.20 | ATP + 6-[[(1R,2R,4R)-bicyclo[2.2.1]hept-5-ene-2-carbonyl]amino]hexanoic acid + a [lipoyl-carrier protein]-L-lysine | - |
Escherichia coli | ? | - |
? | |
6.3.1.20 | ATP + 6-[[(1S,2R,4S)-bicyclo[2.2.1]hept-5-ene-2-carbonyl]amino]hexanoic acid + a [lipoyl-carrier protein]-L-lysine | - |
Escherichia coli | ? | - |
? | |
6.3.1.20 | ATP + 6-[[(1S,2R,4S)-bicyclo[2.2.1]hept-5-ene-2-carbonyl]amino]hexanoic acid + a [lipoyl-carrier protein]-L-lysine | 6-[[(1S,2R,4S)-bicyclo[2.2.1]hept-5-ene-2-carbonyl]amino]hexanoic acid-LAP-eDHFR labeled with tetrazine-fluorescein | Escherichia coli | ? | - |
? | |
6.3.1.20 | ATP + 8-[[(1R,2S,4R)-bicyclo[2.2.1]hept-5-ene-2-carbonyl]amino]octanoic acid + a [lipoyl-carrier protein]-L-lysine | - |
Escherichia coli | ? | - |
? | |
6.3.1.20 | additional information | two-step protein labeling by using lipoic acid ligase with norbornene substrates and subsequent inverse-electron demand Diels-Alder reaction, identification of a potential candidate for use as a norbornene-bearing substrate for LplAW37V-mediated peptide labeling. The norbornene moiety is highly stable in the presence of nucleophiles, and can be efficiently coupled to the 13-aa LAP-tag and further modified with tetrazine fluorophore conjugates in inverse-electron-demand Diels-Alder cycloaddition. The rigid compounds 4-[(3aS,4R,7S,7aS)-1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl]butanoic acid, 5-[(3aS,4R,7S,7aS)-1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl]pentanoic acid, and 6-[(3aS,4R,7S,7aS)-1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl]hexanoic acid are not accepted as substrates at all, likely due to less flexibility and steric hindrance. Derivatives with shorter (4-[[(1R,2S,4R)-bicyclo[2.2.1]hept-5-ene-2-carbonyl]amino]butanoic acid, 5-[[(1R,2S,4R)-bicyclo[2.2.1]hept-5-ene-2-carbonyl]amino]pentanoic acid, and 4-[[(1R,2S,4R)-bicyclo[2.2.1]hept-5-ene-2-carbonyl]amino]butanoic acid) and longer (9-[[(1R,2S,4R)-bicyclo[2.2.1]hept-5-ene-2-carbonyl]amino]nonanoic acid) aliphatic chains are not accepted by LplAW37V, thus indicating the necessity of a particular chain length to fit the dimensions of the active site of LplAW37V | Escherichia coli | ? | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
6.3.1.20 | lipoic acid ligase | - |
Escherichia coli |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
6.3.1.20 | 30 | - |
assay at | Escherichia coli |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
6.3.1.20 | ATP | - |
Escherichia coli |
EC Number | General Information | Comment | Organism |
---|---|---|---|
6.3.1.20 | physiological function | enzyme LplA naturally catalyzes the ligation of lipoic acid to the free epsilon-amino moiety of a lysine residue in the specific LAP sequence | Escherichia coli |